Zajdel Paweł, Marciniec Krzysztof, Satała Grzegorz, Canale Vittorio, Kos Tomasz, Partyka Anna, Jastrzębska-Więsek Magdalena, Wesołowska Anna, Basińska-Ziobroń Agnieszka, Wójcikowski Jacek, Daniel Władysława A, Bojarski Andrzej J, Popik Piotr
Department of Medicinal Chemistry and Department of Clinical Pharmacy, Jagiellonian University Medical College , 9 Medyczna Street, 30-688 Krakow, Poland.
Department of Organic Chemistry, Medical University of Silesia , 4 Jagiellońska Street, 41-200 Sosnowiec, Poland.
ACS Med Chem Lett. 2016 Apr 7;7(6):618-22. doi: 10.1021/acsmedchemlett.6b00056. eCollection 2016 Jun 9.
A series of N1-azinylsulfonyl-3-(1,2,3,6,tetrahyrdopyridin-4-yl)-1H-indole derivatives was designed to obtain highly potent 5-HT6 receptor ligands. The study allowed for the identification of 25 (4-{[5-methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-1-yl]sulfonyl}isoquinoline), a potent and selective 5-HT6 receptor antagonist. The selected compound, was evaluated in vivo in a novel object recognition (NOR) and forced swim (FST) tests in rats, demonstrating distinct pro-cognitive and antidepressant-like properties (MED = 1 mg/kg and 0.1 mg/kg, i.p., respectively). Compound SB-742457, used as comparator, reversed memory deficits in NOR task in similar doses, while in FST it was active in 10-30-fold higher dose (3 mg/kg). In contrast to SB-742457, which was active in Vogel test (MED = 3 mg/kg), compound 25 displayed no anxiolytic activity.
设计了一系列N1-氮杂环基磺酰基-3-(1,2,3,6-四氢吡啶-4-基)-1H-吲哚衍生物,以获得高效的5-HT6受体配体。该研究鉴定出了25(4-{[5-甲氧基-3-(1,2,3,6-四氢吡啶-4-基)-1H-吲哚-1-基]磺酰基}异喹啉),一种强效且选择性的5-HT6受体拮抗剂。对所选化合物在大鼠的新型物体识别(NOR)和强迫游泳(FST)试验中进行了体内评估,结果表明其具有明显的促认知和类抗抑郁特性(MED分别为1 mg/kg和0.1 mg/kg,腹腔注射)。用作对照的化合物SB-742457在类似剂量下可逆转NOR任务中的记忆缺陷,而在FST试验中,其活性剂量高10至30倍(3 mg/kg)。与在Vogel试验中具有活性(MED = 3 mg/kg)的SB-742457不同,化合物25没有抗焦虑活性。